Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.9%

1 terminated out of 17 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

24%

4 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results75% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (7)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Unknown7
Not Yet Recruiting4
Completed3
Recruiting1
Terminated1
Withdrawn1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT07313228Not Yet Recruiting

Pulsed Field Ablation for Non-valvular Atrial Fibrillation After Left Atrial Appendage Occlusion

NCT07257614Not Yet Recruiting

Left Atrial Appendage Occlusion in Dialysis Patients With Atrial Fibrillation: A Multicentre Pilot Study

NCT06969118Not ApplicableNot Yet Recruiting

RCT of Minimalist vs Standard Procedure for LAAC in NVAF Patients

NCT05136417Not ApplicableCompletedPrimary

Study of Intra-Cardiac Echocardiography in Guiding Left Atrial Appendage Occlusion With the Watchman Device

NCT06702865Not Yet Recruiting

Combined Leadless Pacemaker and Left Atrial Appendage Occlusion Registry

NCT06584370Not ApplicableCompleted

Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation

NCT06060912Not ApplicableRecruitingPrimary

LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs

NCT04524741Not ApplicableUnknownPrimary

Use of Intracardiac Echocardiography or Left Atrial Appendage Radiography to Guide Implantation of a Left Atrial Appendage Occlusion Device

NCT05671276Phase 4Unknown

Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion

NCT05632445Phase 4CompletedPrimary

Apixaban vs Dual Antiplatet Therapy Study After Left Atrial Appendage Occlosure (ADALA)

NCT05399342Withdrawn

Left Atrial Appendage Occlusion Study III Extended Follow Up

NCT05554822Phase 3UnknownPrimary

Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study

NCT04524780Not ApplicableUnknownPrimary

Use of Intracardiac Echocardiography or Left Atrial Appendage Radiography to Guide Implantation of a Left Atrial Appendage Occlusion Device.

NCT04897204Not ApplicableUnknown

Left Atrial Appendage Electrical Isolation in Persistent Atrial Fibrillation

NCT04502017Phase 4Unknown

Efficacy of Different Anti-Thrombotic Strategies on Device-Related Thrombosis Prevention After Percutaneous Left Atrial Appendage Occlusion

NCT03987945Unknown

Left Atrial Appendage Occlusion in Patients With Non-valvular Atrial Fibrillation From Shanghai

NCT00841529Phase 2TerminatedPrimary

Evaluation of the Cardioblate Closure Device in Facilitating Occlusion of the Left Atrial Appendage

Showing all 17 trials

Research Network

Activity Timeline